Wire · opportunities
Why AI drug discovery outpaces patient clinical trial recruitment
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 November 2026 · Fusion42 review
AI-driven drug discovery is accelerating, but clinical trial patient recruitment remains a bottleneck due to the outdated recruitment model and geographic concentration of trial sites, hindering timely patient access.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You must shift your clinical trial focus upstream to connect with patients and physicians earlier in the care journey before traditional trial sites get involved. The usual recruitment channels won't deliver enough patients fast enough as personalised medicine demands earlier enrolment.
◆ Coverage
1 source · 20 Nov 2026
◆ Related on Wire
◆ Topics